AFC PREVALENCE TABLE 5B
State/Territory | Sample size± |
One or more routine visits | No routine visits3 | ||||||
---|---|---|---|---|---|---|---|---|---|
Sample size |
% | SE§ | 95% CI† | Sample size |
% | SE | 95% CI | ||
Connecticut | 170 | 117 | 68.9 | 4.6 | (59.2 – 77.2) | 53 | 31.1 | 4.6 | (22.8 – 40.8) |
Hawaii | 125 | 71 | 55.5 | 7.1 | (41.5 – 68.6) | 54 | 44.5 | 7.1 | (31.4 – 58.5) |
Kansas | 230 | 151 | 68.2 | 4.1 | (59.6 – 75.7) | 79 | 31.8 | 4.1 | (24.3 – 40.4) |
Louisiana | 74 | 54 | 75.5 | 6.4 | (61.0 – 85.8) | 20 | 24.5 | 6.4 | (14.2 – 39.0) |
Maine | 95 | 60 | 74.4 | 4.7 | (64.2 – 82.5) | 35 | 25.6 | 4.7 | (17.5 – 35.8) |
Maryland | 205 | 131 | 70.4 | 4.4 | (61.1 – 78.2) | 74 | 29.6 | 4.4 | (21.8 – 38.9) |
Massachusetts | 65 | 43 | 56.9 | 9.4 | (38.4 – 73.6) | 22 | 43.1 | 9.4 | (26.4 – 61.6) |
Michigan | 293 | 223 | 76.2 | 3.2 | (69.5 – 81.8) | 70 | 23.8 | 3.2 | (18.2 – 30.5) |
Mississippi | 162 | 119 | 81.1 | 3.4 | (73.5 – 87.0) | 43 | 18.9 | 3.4 | (13.0 – 26.5) |
Missouri | 111 | 91 | 79.8 | 5.2 | (67.8 – 88.1) | 20 | 20.2 | 5.2 | (11.9 – 32.2) |
Montana | 145 | 97 | 63.5 | 5.5 | (52.2 – 73.5) | 48 | 36.5 | 5.5 | (26.5 – 47.8) |
Nebraska | 290 | 203 | 69.5 | 4.2 | (60.8 – 77.0) | 87 | 30.5 | 4.2 | (23.0 – 39.2) |
New Hampshire | 113 | 83 | 74.6 | 5.4 | (62.6 – 83.8) | 30 | 25.4 | 5.4 | (16.2 – 37.4) |
New Jersey | 289 | 215 | 73.9 | 4.1 | (65.2 – 81.0) | 74 | 26.1 | 4.1 | (19.0 – 34.8) |
New Mexico | 146 | 91 | 63.1 | 5.1 | (52.7 – 72.3) | 55 | 36.9 | 5.1 | (27.7 – 47.3) |
New York | 80 | 65 | 79.5 | 7.4 | (61.5 – 90.4) | 15 | N/A | N/A | (N/A – N/A) |
Ohio | 165 | 122 | 73.9 | 5.3 | (62.1 – 82.9) | 43 | 26.1 | 5.3 | (17.1 – 37.9) |
Oklahoma | 127 | 87 | 72.2 | 5.0 | (61.5 – 80.8) | 40 | 27.8 | 5.0 | (19.2 – 38.5) |
Oregon | 64 | 43 | 66.6 | 7.0 | (51.9 – 78.7) | 21 | 33.4 | 7.0 | (21.3 – 48.1) |
Pennsylvania | 256 | 194 | 76.1 | 3.8 | (67.8 – 82.8) | 62 | 23.9 | 3.8 | (17.2 – 32.2) |
Rhode Island | 84 | 54 | 65.9 | 7.8 | (49.4 – 79.2) | 30 | 34.1 | 7.8 | (20.8 – 50.6) |
Texas | 217 | 156 | 72.5 | 4.5 | (62.9 – 80.4) | 61 | 27.5 | 4.5 | (19.6 – 37.1) |
Utah | 331 | 216 | 68.1 | 3.1 | (61.8 – 73.8) | 115 | 31.9 | 3.1 | (26.2 – 38.2) |
Washington | 159 | 104 | 65.1 | 5.0 | (54.8 – 74.1) | 55 | 34.9 | 5.0 | (25.9 – 45.2) |
West Virginia | 113 | 75 | 66.0 | 5.5 | (54.7 – 75.8) | 38 | 34.0 | 5.5 | (24.2 – 45.3) |
Wisconsin | 103 | 66 | 62.6 | 7.0 | (48.4 – 75.0) | 37 | 37.4 | 7.0 | (25.0 – 51.6) |
26 state total | 4,212 | 2,931 | 72.5 | 1.5 | (69.5 – 75.3) | 1,281 | 27.5 | 1.5 | (24.7 – 30.5) |
Median | 70.0 | 30.5 | |||||||
Range | 55.5-81.1 | 18.9-44.5 |
1 Aged < 18 years
2 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma
3 No doctor visits or no routine doctor visits
± Sample size is for multiple years of participation. Responses of “Don’t Know” and “Refused” are excluded.
§ Standard error
† Confidence interval
N/A: Estimate not available (N/A) if the relative standard error was > 0.30
Page last reviewed: September 10, 2018